Of note, the majority of studies included both CD and ulcerative colitis (UC) patients, and patients on concomitant TNF-α inhibitors, which impedes meaningful analysis of drug efficacy [17, 19–21]. This evidence concerns the gene TNF and ulcerative colitis.